Abstract
The nasal cavity and paranasal sinuses are in close anatomical proximity to many essential structures and also offer conditions in which tumours can grow for substantial periods of time before tumour growth becomes restricted. Hence, sinonasal malignancies can attain a significant size prior to the patient presenting, necessitating an aggressive approach in treating tumours growing near to the base of the skull, the orbital cavities, the cranial nerves and major blood vessels. Whilst sinonasal malignancies (SNM) are seldom seen, when they do occur, they are of grave concern. Typically, the patient remains asymptomatic at an early stage of tumour growth, a situation compounded by the tumour mimicking the symptoms of other frequently encountered, but less grave conditions (such as a nosebleed on one side or a blocked nose). When such mimicry occurs, both the patient and doctor may frequently discount, or fail adequately to account for the seriousness of the underlying pathology, erroneously treating the neoplasia as a benign, non-neoplastic disorder. Once signs or symptoms more easily associated with malignancy appear (e.g. a headache that is both very marked and fails to respond to treatment, disturbed vision or cranial nerve signs), the tumour may already be advanced. Anatomical considerations are responsible for the late presentation of malignant sinonasal tumours and the difficulty in treating them. Tumours arise in areas abutting vital anatomical structures such as the base of the skull, the orbits, the path of cranial nerves and major blood vessels. Surgical removal of these neoplasms results in evident morbidity and marked complications. Effective treatment calls for multidisciplinary team working, ideally with representation from the following specialties: surgical oncology (head and neck), reconstructive surgery, maxillofacial prosthodontics, radiotherapy, medical oncology, neuroradiology, histopathology and neurosurgery and the patient him- or herself.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Klem C. Malignant tumors of the sinuses treatment & management. In: Meyers AD (Ed.). Medscape. http://emedicine.medscape.com/article/847189-treatment#showall (Accessed online at April 23, 2016).
Robin PE, Powell DJ, Stansbie JM. Carcinoma of the nasal cavity and paranasal sinuses: incidence and presentation of different histological types. Clin Otolaryngol Allied Sci. 1979;4(6):431–56.
Bridger GP, Mendelsohn MS, Baldwin M, Smee R. Paranasal sinus cancer. Aust N Z J Surg. 1991;61(4):290–4.
Golabek W, Drop A, Golabek E, Morshed K. Site of origin of paranasal sinus malignancies. Pol Merkuriusz Lek. 2005;(111):413–4. (in Polish)
Larsson LG, Martensson G. Carcinoma of the paranasal sinuses and the nasal cavities; a clinical study of 379 cases treated at Radiumhemmet and the Otolaryngologic Department of Karolinska Sjukhuset, 1940–1950. Acta Radiol. 1954;42(2):149–72.
Bornholdt J, Hansen J, Steiniche T, et al. K-ras mutations in sinonasal cancers in relation to wood dust exposure. BMC Cancer. 2008;8:53.
Klintenberg C, Olofsson J, Hellquist H, Sokjer H. Adenocarcinoma of the ethmoid sinuses. A review of 28 cases with special reference to wood dust exposure. Cancer. 1984;54(3):482–8.
Luce D, Gerin M, Leclerc A, Morcet JF, Brugere J, Goldberg M. Sinonasal cancer and occupational exposure to formaldehyde and other substances. Int J Cancer. 1993;53(2):224–31.
Katori H, Nozawa A, Tsukuda M. Markers of malignant transformation of sinonasal inverted papilloma. Eur J Surg Oncol. 2005;(8):905–11.
McKay SP, Gregoire L, Lonardo F, Reidy P, Mathog RH, Lancaster WD. Human papillomavirus (HPV) transcripts in malignant inverted papilloma are from integrated HPV DNA. Laryngoscope. 2005;115(8):1428–31.
Ott G, Kalla J, Ott MM, Muller-Hermelink HK. The Epstein-Barr virus in malignant non-Hodgkin's lymphoma of the upper aerodigestive tract. Diagn Mol Pathol. 1997;6(3):134–9.
Tiwari R, Hardillo JA, Mehta D, et al. Squamous cell carcinoma of maxillary sinus. Head Neck. 2000;22(2):164–9.
Batsakis JG, Rice DH, Solomon AR. The pathology of head and neck tumors: squamous and mucous-gland carcinomas of the nasal cavity, paranasal sinuses, and larynx, part 6. Head Neck Surg. 1980;2(6):497–508.
Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83(8):1664–78.
Rosenthal DI, Barker JL Jr, El-Naggar AK, et al. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Cancer. 2004;101(11):2567–73.
Rischin D, Porceddu S, Peters L, Martin J, Corry J, Weih L. Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma. Head Neck. 2004;26(5):435–41.
Kapadia SB, Barnes L, Deutsch M. Non-Hodgkin's lymphoma of the nose and paranasal sinuses: a study of 17 cases. Head Neck Surg. 1981;3(6):490–9.
Abbondanzo SL, Wenig BM. Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases. Cancer. 1995;75(6):1281–91.
Petrella T, Delfau-Larue MH, Caillot D, et al. Nasopharyngeal lymphomas: further evidence for a natural killer cell origin. Hum Pathol. 1996;27(8):827–33.
Kimura Y, Tanaka S, Furukawa M. Angiosarcoma of the nasal cavity. J Laryngol Otol. 1992;106(4):368–9.
Nappi O, Wick MR. Sarcomatoid neoplasms of the respiratory tract. Semin Diagn Pathol. 1993;10(2):137–47.
Carrau RL. Malignant tumors of the nasal cavity. In: Meyers AD (Ed). Medscape. http://emedicine.medscape.com/article/846995-overview#showall (Accessed online at April 23, 2016).
Jackson RT, Fitz-Hugh GS, Constable WC. Malignant neoplasms of the nasal cavities and paranasal sinuses: (a retrospective study). Laryngoscope. 1977;87(5. Pt 1):726–36.
Zimmer LA, Carrau RL Neoplasms of the nose and paranasal sinuses. In: Bailey BJ, Johnson JT, Newland SD, eds. Head & neck surgery—otolaryngology, 4th ed., Lippincott Williams & Wilkins; 2006.
Su SY, Kupferman ME, DeMonte F, Levine NB, Raza SM, Hanna EY. Endoscopic resection of sinonasal cancers. Curr Oncol Rep. 2014;16(2):369. https://doi.org/10.1007/s11912-013-0369-6.
Swegal W, Koyfman S, Scharpf J, et al. Endoscopic and open surgical approaches to locally advanced sinonasal melanoma: comparing the therapeutic benefits. JAMA Otolaryngol Head Neck Surg. 2014;140(9):840–5.
Hadad G, Bassagasteguy L, Carrau RL, et al. A novel reconstructive technique after endoscopic expanded endonasal approaches: vascular pedicle nasoseptal flap. Laryngoscope. 2006;116(10):1882–6. [Medline]
Nicolai P, Battaglia P, Bignami M, et al. Endoscopic surgery for malignant tumors of the sinonasal tract and adjacent skull base: a 10-year experience. Am J Rhinol. 2008;22(3):308–16.
Lund V, Howard DJ, Wei WI. Endoscopic resection of malignant tumors of the nose and sinuses. Am J Rhinol. 2007;21(1):89–94.
Goffart Y, Jorissen M, Daele J, Vander Poorten V, Born J, Deneufbourg JM, Zicot AF, Remacle JM. Minimally invasive endoscopic management of malignant sinonasal tumours. Acta Otorhinolaryngol Belg. 2000;54(2):221–32.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Özgür, E., Üçüncü, H., Jurlina, M. (2020). Endoscopic Management of Malignant Sinonasal Tumours. In: Cingi, C., Bayar Muluk, N. (eds) All Around the Nose. Springer, Cham. https://doi.org/10.1007/978-3-030-21217-9_71
Download citation
DOI: https://doi.org/10.1007/978-3-030-21217-9_71
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21216-2
Online ISBN: 978-3-030-21217-9
eBook Packages: MedicineMedicine (R0)